Angiopoietin-1 protects myocardial endothelial cell function blunted by angiopoietin-2 and high glucose condition

Acta Pharmacologica Sinica

Volumn 32, Issue 1, 2011, Pages 45-51

  Tuo, Qin Hui ^a,b   Xiong, Guo Zuo ^c   Zeng, Heng ^a   Yu, Hei Di ^a   Sun, Shao Wei ^b   Ling, Hong Yan ^b   Zhu, Bing Yang ^b   Liao, Duan Fang ^b,d   Chen, Jian Xiong ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH CHINA   (China)

^c THE SECOND AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

^d HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

angiopoietin; diabetic; hyperglycemia; myocardial endothelial cells; Tie 2

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; CASPASE 3; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; PROTEIN KINASE B; TIE RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; GLUCOSE; MICE; MYOCARDIUM; RECEPTOR, TIE-2;

EID: 78651069978     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2010.183     Document Type: Article

References (21)

1. Tuo QH, Zeng H, Stinnett A, Yu H, Aschner JL, Liao DF, et al. Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis. Am J Physiol Heart Circ Physiol 2007; 292: H1664-74.
2. Farhangkhoee H, Khan ZA, Kaur H, Xin X, Chen S, Chakrabarti S. Vascular endothelial dysfunction in diabetic cardiomyopathy: Pathogenesis and potential treatment targets. Pharmacol Ther 2006; 111: 384-99.
3. Wang YL, Hui YN, Guo B, Ma JX. Strengthening tight junctions of retinal microvascular endothelial cells by pericytes under normoxia and hypoxia involving angiopoietin-1 signal way. Eye (Lond) 2007; 21: 1501-10.
4. Kugathasan L, Ray JB, Deng Y, Rezaei E, Dumont DJ, Stewart DJ. The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice. J Exp Med 2009; 206: 2221-34.
5. Park JS, Seo J, Kim YO, Lee HS, Jo I. Coordinated regulation of angiopoietin-1 and vascular endothelial growth factor by arsenite in human brain microvascular pericytes: Implications of arsenite-induced vascular dysfunction. Toxicology 2009; 264: 26-31.
6. Chen JX, Stinnett A. Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice. Arterioscler Thromb Vasc Biol 2008; 28: 1606-13.
7. Tuo QH, Liao DF. The ratio of Ang-1/Ang-2 in vessel diseases. Chin J Arterioscler 2009; 17: 414-6.
8. QH Tuo, C Wang, FX Yan, DF Liao. MAPK pathway mediates the protective effects of onychin on oxidative stress-induced apoptosis in ECV304 endothelial cells. Life Sci 2004; 76: 487-97.
9. Tuo QH, Liang L, Zhu BY, Cao X, Liao DF. The effect of Daxx on the cholesterol accumulation in hepatic cells. World J Gastroenterol 2008; 14: 435-40.
10. Lovren F, Pan Y, Shukla PC, Quan A, Teoh H, Szmitko PE, et al. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: Translational implications for atherosclerosis. Am J Physiol Endocrinol Metab 2009; 296: E1440-9.
11. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233-40.
12. Singh H, Brindle NP, Zammit VA. High glucose and elevated fatty acids suppress signaling by the endothelium protective ligand angiopoietin-1. Microvasc Res 2010; 79: 121-7.
13. Minhas N, Xue M, Fukudome K, Jackson CJ. Activated protein C utilizes the angiopoietin/Tie2 axis to promote endothelial barrier function. FASEB J 2010; 24: 873-81.
14. Gomei Y, Nakamura Y, Yoshihara H, Hosokawa K, Iwasaki H, Suda T, et al. Functional differences between two Tie2 ligands, angiopoietin-1 and -2, in regulation of adult bone marrow hematopoietic stem cells. Exp Hematol 2010; 38: 82-9.
15. Fujikawa K, de Aos Scherpenseel I, Jain SK, Presman E, Christensen RA, Varticovski L. Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells. Exp Cell Res 1999; 253: 663-72.
16. Huang J, Bae JO, Tsai JP, Kadenhe-Chiweshe A, Papa J, Lee A, et al. Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade. Int J Oncol 2009; 34: 79-87.
17. Chen JX, Lawrence ML, Cunningham G, Christman BW, Meyrick B. HSP90 and Akt modulate Ang-1-induced angiogenesis via NO in coronary artery endothelium. J Appl Physiol 2004; 96: 612-20.
18. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-4.
19. Kern J, Bauer M, Rychli K, Wojta J, Ritsch A, Gastl G, et al. Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation. Arterioscler Thromb Vasc Biol 2008; 28: 478-84.
20. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60.
21. Yang M, Zhang M, Chen J, Mukherjee R, Zhang L, Lin S, et al. Angiopoietin-1 inhibits mouse glomerular endothelial cell senescence via Tie2 receptor-modulated ERK1/2 signaling. Am J Nephrol 2010; 31: 490-500.